Pigmented skin lesions refers to melanocytic as well as nonmelanocytic lesions. Pigmentation is not just a cosmetic deformity but can also reflect underlying benign pathology as nevi or malignant lesions as melanoma. With this study we intend to evaluate the spectrum of pigmented skin lesions and to correlate the clinical diagnosis with the histological diagnosis. Materials and Methods: This is a hospital based cross sectional descriptive study where clinicohistopathological evaluation of 46 cases of pigmented skin lesions were analyzed on paraffin embedded tissue sections for a duration of 1 year at the Department of Pathology, B. P. Koirala Institute of Health Sciences. Results: Out of the 46 cases evaluated there were 32 cases of melanocytic lesions comprising of benign melanocytic nevi (n=27), malignant melanoma (n=5) and 14 cases of nonmelanocytic lesions including basal cell carcinoma and seborrhoeic keratosis (5 cases each). Angiokeratoma (n=1), sebaceous hyperplasia (n=1), trichoepitheloma (n=1) and venous haemangioma (n=1). The age range was from 8-83 years with slight female predominance (52.2%) and the most common site involved was head and neck (58.7%). 76.1% of the patients belonged to the Terai region. Clinicohistopathological correlation showed positive correlation in 26 cases (56.5%) and negative correlation in 20 cases (43.5%). Conclusion: Pigmented skin lesions are common presenting problem, while majority are benign a small minority can be malignant. So, clinically pigmented skin lesions should be submitted for pathological examination in order not to miss a small percentage of malignant tumors and to differentiate melanocytic lesions from its nonmelanocytic mimickers.
INTRODUCTION
Pigmented skin lesions (PSLs) include both melanocytic as well as nonmelanocytic lesions. 1 Disorders of pigmentation can result from migration abnormalities of melanocytes from neural crest to the skin during embryogenesis, impairment of melanosome transfer to keratinocytes and alteration in melanin synthesis. 2 Melanocytes are pigment-producing cells. The function of melanocytes is the production of melanin, Melanin protects the mitotically active basal epidermal cells from the injurious effects of ultraviolet light, which accounts for individuals with less pigmentation having a much greater risk of sunburn and developing cutaneous malignancies like squamous cell carcinoma, basal cell carcinoma, and melanoma. 3 Pigmentation is not just a cosmetic deformity causing psychosocial upset but can also reflect underlying pathology as nevi and other benign pigmented lesions are important precursor of malignant melanoma. 1 Melanocytic proliferations are composed of one or more of three related cell types; melanocytes, nevus cells or melanoma cells, each of which may be in epidermis or dermis and occasionally in subcutis. Benign tumors of nevus cells are called melanocytic nevi, while malignant tumors are called malignant melanoma. 4 Melanoma accounts for about 5% of all skin cancers but, according to American Cancer Society, causes 77% of all skin cancer related deaths. As per the 2008, United States cancer statistics showed that melanoma of the skin was the fifth most common cancer in men and the seventh most common cancer in women. As per the 2005 -2009 data, the age adjusted incidence rate for cutaneous melanoma is 21.0 per 100,000 per year. 5 Many nonmelanocytic skin lesions have pigmented variants that can defy clinical recognition and mimic clinically melanocytic lesions including malignant melanoma, such mimickers include seborrhoeic keratosis, basal cell carcinoma, actinic keratosis, dermatofibrosarcoma protuberans, lichen planus pigmentosus. Histopathological examination helps to confirm/refute the clinical diagnosis and helps in treatment of patients with PSLs. 6 With this study, we intend to evaluate the spectrum of PSLs and to correlate the clinical diagnosis with the histological diagnosis.
MATERIALS AND METHODS
A hospital based cross sectional descriptive study spanning over a period of 1 year, from July 2015 to June 2016, was carried out at the Department of Pathology, B. P. Koirala Institute of Health Sciences (BPKIHS). A total of 46 patients of all age groups having PSL clinically and/ or confirmed by histopathology were included in the study. PSLs were analysed considering the histologic type, anatomic location, tumor type, along with age, sex and geographical distribution of the patient. Patient or patient party who fail to give consent or history with inflammatory, infectious, metabolic and endocrine lesions are excluded from the study.
For histopathological examination, Hematoxylin and Eosin stained formalin fixed paraffin embedded tissue sections were examined. Special stains were performed whenever necessary (Masson Fontana and Melanin bleach). All the slides were evaluated by consultant pathologist.
Ethical clearance was obtained from Institutional Review Committee, BPKIHS. (Acd/374/'072/'073) The collected data was entered in Microsoft Office Excel 2007 software. Data analysis was done by using SPSS (Statistical Package for Social Sciences) 11.5 versions. The study considered 95% confidence interval. Population enumeration was used for sampling technique.
RESULTS
Histopathological study of 46 cases of PSLs were evaluated where maximum cases encountered was benign melanocytic nevi (27), malignant melanoma, basal cell carcinoma and seborrhoeic keratosis were found in equal frequency (5 cases each). Angiokeratoma (1), sebaceous hyperplasia (1), trichoepitheloma (1) and venous haemangioma (1) were the lesions which did not contribute to a significant proportion.
In the study population, the age ranged from 8 -83 years. Benign melanocytic nevi was seen most commonly in the age group 20-40 years (n=15, 55.60%). All the cases (5 each) of malignant melanoma, pigmented BCC and seborrhoeic keratosis were seen in patient more than 40 years of age. In the current study 52.2% were female and 47.8% were male.
Most common site involved was head and neck (n=27, 58.7%), followed by trunk (n=11, 23.9%), lower limbs (n=7, 15.2%) and upper limbs (n=1, 2.2%). All the 5 cases of malignant melanoma were seen in lower limbs. Pigmented basal cell carcinoma (BCC) were seen in head and neck (n=4, 80%) and only (n=1, 20%) were seen in lower limb.
According to Geographic distribution majority of the patients (n=35, 76.1%) belonged to Terai region and remaining (n=11, 23.9%) patients from Hilly regions. DOI : 10.3126/jpn.v9i2.24080 In this study an analysis of the clinical diagnosis with the histopathological diagnosis revealed a positive correlation in 26 cases (56.5%) and negative correlation in 20 cases (43.5%) ( Table 2) .
The present study included 5 cases of malignant melanoma. Clarks grading of malignant melanoma revealed grade 4 and 5 tumor in 40% cases each, while grade 2 was seen in 20% cases only.
Four cases showed Breslow's depth in stage 1 which predicts good prognosis while 1 case was in stage 2 which predicts bad prognosis. Patient with stage 2 Breslow in the study presented with metastasis to liver. Of the 5 cases of primary melanoma ulcer was reported in 3 cases.
DISCUSSION
In this study we studied the spectrum of pigmented skin lesions and their mimickers. Histopathologic examination serves as a complementary or a confirmative part of diagnosis.
The median age of patients in current study was found to be 42.5 years with malignant cases seen in older patients as compared to benign. Benign melanocytic nevi was seen most commonly in the age group 20-40 years which is concordant with study performed by Laishram R et al. 7 Malignant melanoma and pigmented BCC were seen in patients above 40 years of age which is similar to study by Dafe Forae G et al where majority of the malignant skin tumors occurred between the third to fifth decades and peak age for malignant melanoma was fifth decade. 8 10 The higher number of lesions removed from female can be attributed to behavioral difference between male and female patient in seeking medical attention. 10 Kwok Y et al in their study on melanocytic nevi concluded, that majority of patients were women, which is similar to this study. 11 There was considerable geographic variation in the incidence of PSLs where 76.1% patients belonged to Terai region and only 23.9% patients were from hilly region. This variation can be related to exposure to sunlight and the susceptibility of the population. In a study done by Harrison S et al on body-site distribution of melanocytic nevi in young Australian children they found that melanocytic nevi are distributed over the body in a way that implicates exposure to sunlight. 12 Newton-Bishop JA et al and Boniol M et al in their study also concluded that sun-sensitive phenotypes and reported sunburn were associated with an increased risk of melanoma. 13, 14 The most common site involved in this study was head and neck (58.7%), followed by trunk (23.9%), lower limbs (15.2%) and upper limbs (2.2%) which is concordant with DOI : 10.3126/jpn.v9i2.24080 1, 6, 7 In a study performed by Valiukeviciene S et al, it was concluded that median densities of nevi was highest on the face which is similar to this study. 15 It was reported from Japan that 86% of skin melanomas were found in lower limbs and most of these were found in the sole which is comparable to this study where all the cases of malignant melanoma were seen in lower limbs. 16 All the cases of BCC were seen in head and neck which is similar to study done by Kumar S et al where head and neck region was involved in 97.2% of cases. 17 In this study, maximum cases were hyperpigmented 84.8%, however 15.2% were skin colored. The skin colored lesions included benign melanocytic nevi (n=6) and pigmented BCC (n=1). Hawsawi K et al reported a case where benign melanocytic nevi presented as solitary firm skin colored nodule, which was later confirmed on histopathology as nevi. 18 According to literature benign melanocytic nevi can present as localized pigmented or non-pigmented lesions. 4 In this study, the accuracy of diagnosing benign melanocytic nevi was found to be 63.04%, whereas accuracy in diagnosis of malignant melanoma was 95.65%. In a study done by Brochez L et al, overall there was 70% agreement on the diagnostic classification of benign melanocytic lesions. Brochez L et al also evaluated the inter-observer variation of 20 pathologists in the histological diagnosis of a randomly selected set of suspicious PSLs, by comparing their diagnoses to a reference diagnosis. Overall sensitivity for melanoma was 87%, ranging from 55% to 100% between the observers. 19 Increased awareness of melanoma among health professionals and the public has led to an increase in the number of biopsies of PSLs over time. In the case of melanoma, the pathologist evaluates some tumor characteristics which can affect prognosis and patient management, such as the Breslow thickness and the presence or absence of ulceration. 19 Comparison of Clarks leveling of malignant melanoma of current study was done with those of studies performed by (Table 3) . 1, 9, 20, 21 Of the 7 cases of melanoma diagnosed clinically only 5 were confirmed microscopically. The remaining 2 inconsistent case was of pigmented BCC. There were 5 cases of pigmented basal cell carcinoma diagnosed on histology which had been clinically misdiagnosed as benign melanocytic nevi (n=2), melanoma (n=2) and seborrhoeic keratosis (n=1). Anderson W et al, in their study on 178 cases of malignant melanoma, had described 2 subsets of melanoma which defy clinical diagnosis, one of which is mistaken for basal cell carcinoma and the other with verrucous appearance is mistaken for seborrheic keratosis. 22 In study done by Izikson L et al on prevalence of melanoma clinically resembling seborrheic keratosis melanoma was identified in 61 cases (0.66%) submitted for histological examination with a clinical diagnosis that included seborrheic keratosis. 23 A total of 32 cases were confirmed to be melanocytic tumors histologically. Non-melanocytic skin lesions commonly diagnosed as melanocytic tumors clinically included seborrhoeic keratosis, pilar cyst, dermatofibroma, papilloma and neurofibroma. Crasta J et al reported basal cell carcinoma, seborrhoeic keratosis, actinic keratosis and dermatofibrosarcoma protuberans to be the common nonmelanocytic tumors that resemble melanocytic tumors. 6 In study done by Suvernakar S et al. the melanocytic group comprised of benign melanocytic nevi, dysplastic nevi and malignant melanoma while seborrhoeic keratosis, pigmented actinic keratosis and pigmented basal cell carcinoma comprised the non-melanocytic lesions. 1 Leung K et al reported that non-melanocytic skin lesions commonly diagnosed as melanocytic tumors clinically included seborrheic keratosis, haematoma, skin tag, dermatofibroma, wart, basal cell carcinoma and inflammatory pigmentation. 10 Curley RK et al reported an overall sensitivity (diagnostic accuracy) of 50% in clinically evaluating pigmented lesions. 24 This emphasizes the importance and utility of histopathology in arriving at a conclusive diagnosis.
CONCLUSIONS
PSLs are very common presenting problem, while majority are benign, a small minority can be malignant. Histopathological examination of clinically PSLs differentiates between melanocytic and nonmelanocytic lesions and identifies malignant tumours. Since early detection and treatment of lesions are crucial to decrease functional and cosmetic morbidity and costs, histopathological examination of PSLs is essential.
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